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OVERVIEW — This background paper provides a review of mental health
coverage in the Medicare program. It examines the prevalence of mental
disorders among Medicare beneficiaries, treatment available through Medicare, and the cost of such treatment. A brief summary of relevant policy
issues is provided, including Medicare’s outpatient mental health limitation and the potential effect of the prescription drug benefit on the provision of mental health services.
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Medicare and Mental Health:
The Fundamentals
The Medicare prescription drug benefit has drawn attention to the mental
health care needs of Medicare beneficiaries. This visibility is likely to become more pronounced once the initial tab for psychotropic drugs under
Part D is tallied. Press coverage highlighted the transition problems faced
by mentally ill beneficiaries dually eligible for Medicare and Medicaid,
as well as the high prices paid by Medicare drug plans for psychotropic
drugs. Although psychotropic drugs are an important dimension of
mental health treatment, providing appropriate mental health services
to Medicare’s disabled and aged beneficiaries is a broader challenge than
simply ensuring access to medications. Many mental health professionals
contend that Medicare’s benefit structure is not optimally designed to support the kinds of mental health services demonstrated to be most effective
for disabled and older Americans.
As the prescription drug utilization and spending patterns of Medicare
beneficiaries unfold over time, a broader examination of Medicare’s mental
health coverage and payment policies may occur. When Medicare was
first established in 1965, its benefit package was closely modeled after
the typical commercial health insurance product of the time—a product
that offered very limited coverage for mental health services. Traditional
health insurance policies often singled out mental health services for more
restricted benefits because of concerns that prevailing treatments were of
questionable efficacy and that subjective diagnostic standards made the
benefit particularly vulnerable to overuse. In creating the Medicare program, few policymakers saw little impetus to depart from this conventional
wisdom regarding the structure of mental health benefits.
Over the past 40 years, a number of changes have taken place in the financing
and delivery of mental health services. Science has become increasingly adept at explaining how behavioral manifestations of mental illness are linked
to biological mechanisms that disrupt brain and nervous system functions.
As this evidence base has expanded, the diagnosis and treatment of mental
health disorders has improved. Scientific and clinical advances, combined
with legislative mandates and a growing understanding of how mental
disorders influence general health status, have also increased insurers’
willingness to pay for mental health treatments. A variety of employersponsored health insurance products have evolved to provide more
extensive coverage for mental health while managing utilization in more
sophisticated ways. Despite these changes, Medicare’s coverage for mental
health services has evolved only modestly since the program’s inception.
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Medicare’s benefit structure has, until recently, concealed the impact of mental illness on beneficiary
health, service use, and overall program costs.
Mental disorders are at least as prevalent among
beneficiaries as they are in the general population,
yet Medicare spending on mental health has not
matched that of other payers. Program policies that
do not support preferred models of care have likely
affected beneficiaries’ treatment and outcomes for
some time. Outpatient mental health coverage
restrictions, originally intended to minimize inappropriate service utilization, have the potential to
foster an excessive reliance on pharmacological
interventions and could contribute to higher utilization of other, more expensive health care services,
such as hospitalizations.

A Word of Caution
Prevalence estimates for mental disorders
within the Medicare population are likely to
be understated. Prevalence of mental disorders in the general adult population has been
determined through methodologically robust
epidemiological studies that relied on standard
clinical diagnostic criteria to identify persons
with mental disorders and assessed the severity of confirmed cases. In contrast, prevalence
estimates for the Medicare population rely
solely on service utilization history to identify
persons with mental health diagnoses. In reality,
people who may not actually require treatment
receive services—and people who need care do
not receive it—yielding imprecise estimates of
disease prevalence as a result of both over- and
undercounting of cases. Rigorous studies of the
prevalence of mental disorders in the general
population indicate that undercounting dominates, suggesting that prevalence estimates for
Medicare beneficiaries are conservative.

New spending on psychotropic drugs and demographic changes in the beneficiary population will
soon collide to raise the prominence of mental
health issues within Medicare. The number of Medicare beneficiaries with mental illness is expected to
grow substantially as a result of a variety of factors,
including the large cohort of “baby boomers” aging into the program, longer life expectancies and
the increasing prevalence of dementia and other
cognitive disorders that come with advanced age, and an increase in the
number of Americans qualifying for Social Security benefits (and thus for
Medicare) on the basis of disability due to mental illnesses.1 At the same
time, Part D–related expenses for psychotropic drugs are likely to more
than double current mental health spending by Medicare. The convergence
of these trends suggests a large increase in mental health spending over
the next 15 years.
Managing the cost and quality of care for chronic diseases in a largely
fee-for-service context has long proved to be a difficult struggle for Medicare—and this struggle is abundantly apparent with respect to mental
disorders. The diverse mix of services, providers, and care modalities
inherent in mental health treatment, along with the cognitive limitations
of people with mental disorders, combine to make utilization management
and care coordination especially challenging.

Mental disorders AND Medicare Beneficiaries
Medicare beneficiaries appear as likely to experience mental health
problems as the general adult population.2 Over a 12-month period, approximately 26 percent of Medicare beneficiaries report having some type
of mental disorder,3 compared to 26.2 percent of all noninstitutionalized
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Growth in Disability Awards Related to Mental Disorders
Beneficiaries with disabilities account for a
relatively small proportion of all Medicare beneficiaries, but this group has grown rapidly in
recent years. The number of disabled Medicare
beneficiaries more than doubled between 1990 and
2005, with increasing numbers of disability awards
due to mental illness being a major source of this
growth. Disabled beneficiaries currently represent
nearly 14 percent of all persons who are covered by
Medicare. Growth in the number of beneficiaries
with disabilities has been attributed to a number
of policy changes rather than changes in underlying disease prevalence. Policy changes clarified
Social Security’s disability determination criteria,
resulting in more approvals and fewer terminations. Several of these changes focused specifically
on liberalizing the disability determinations for
mental disorders, such as tying determinations
to functionality assessments and mandating review by a specialty mental health provider in all
appealed denials. People judged to be disabled
and awarded Social Security Disability Insurance
benefits are eligible for Medicare on the basis of
their disability.

SSDI Awards to Disabled Workers
800,000

600,000

400,000

200,000

Total SSDI
Awards
Mental Disorder
Awards

0
Years: 1960 – 2004*

*Data were not available for the years 1964, 1965, 1966, 1974, 1979,
and 1980. The trends are shown as continuous, but the data have been
extrapolated.
Source: Social Security Administration, “Annual Statistical Report on
the Social Security Disability Insurance Program, 2004,” March 2006,
p. 98; available at www.ssa.gov/policy/docs/statcomps/di_asr/2004/index.
html#editions.

adults over the age of 18.4 These prevalence estimates reflect the inclusive
definition of mental disorder used in the Diagnostic and Statistical Manual
of Mental Disorders (DSM), which identifies a wide variety of mental health
diagnoses, including mood disorders (such as depression), anxiety disorders, psychoses, cognitive impairments (such as Alzheimer’s disease),
and substance abuse. The severity of these disorders can vary significantly,
both within and across diagnostic categories.
As is the case in the general adult population, a relatively small proportion
of all Medicare beneficiaries experience severe mental disorders (such as
schizophrenia or major depression) that result in significant functional
impairment. About 9 percent of Medicare beneficiaries have a severe
mental disorder, compared to 6 percent of the general adult population
(Figure 1, following page).5 However, the overall prevalence rate of severe
illness among Medicare beneficiaries obscures important differences in
the burden of disease in the aged beneficiary population relative to those
who are eligible for Medicare due to disability.
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Mental Disorders Among Disabled Beneficiaries
Severe mental illness is highly prevalent among Medicare beneficiaries
under the age of 65 who qualify for Medicare because of a disability. Approximately 37 percent of disabled Medicare beneficiaries have a severe
mental disorder,6 compared to only 4 percent of aged beneficiaries.7 The
high rate of mental disorders in the disabled Medicare population is primarily driven by the large proportion of disabled beneficiaries who qualify
for Medicare because of a long-lasting and disabling mental illness. Since
1987, both the number and proportion of disability awards due to mental
illness have increased dramatically. Mental disorders were the leading
reason disabled workers received Social Security Disability Insurance
(SSDI) in 2004.8
People who qualify for Medicare based on a physical disability may also
have comorbid, potentially severe, mental disorders, and the prevalence of
all types of mental disorders appears high for this population. An estimated
59 percent of all disabled beneficiaries have some type of mental disorder,
compared to 21 percent of aged beneficiaries.9 The rate of severe mental
illness among the physically disabled is not well documented.
Even with Medicare’s limited benefits, care for disabled beneficiaries with
mental disorders is costly. Excluding persons with end-stage renal disease,

figure 1
Prevalence of Mental Disorders

Sources: William E. Narrow et al., “Revised Prevalence Estimates of Mental Disorders in the United
States,” Archives of General Psychiatry, 59, Feb 2002; Ronald C. Kessler et al., “Prevalence and
Treatment of Mental Disorders, 1990 to 2003,” New England Journal of Medicine, 352, no. 24 (June
15, 2005), pp. 2515–2523; Henry J. Kaiser Family Foundation, Medicare Chartbook (Menlo Park, CA:
Henry J. Kaiser Family Foundation, 3rd ed., Summer 2005), available at www.kff.org/medicare/upload/
Medicare-Chart-Book-3rd-Edition-Summer-2005-Report.pdf.; Ronald C. Kessler et al., “Estimating the
Prevalence and Correlates of SMI in Community Epidemiological Studies,” chap. 12 in Mental Health,
United States, 2002, Ronald W. Manderscheid and Marilyn J. Henderson, (Eds.), DHHS Publication
No. SMA04-3938 (Rockville, MD: U.S. Department of Health and Human Services, 2002), available at
http://mentalhealth.samhsa.gov/publications/allpubs/sma04-3938/Chapter12.asp; and Sandra M. Foote
and Christopher Hogan, “Disability Profile And Health Care Costs Of Medicare Beneficiaries Under
Age Sixty-Five,” Health Affairs, 20, no.6 (November/December, 2001), pp. 242–253, available at http://
content.healthaffairs.org/cgi/reprint/20/6/242.pdf.
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figure 2
Disabled Medicare Beneficiaries Under 65:
Medicaid Eligibility and Health Care Costs, 1995
Medicaid
Eligible

Beneficiary Type

43%

All Disabled

Medicare Cost Per Person Per Year
$ 3,832

DISABLED WITH:

62%

Any Mental Disorder

$ 4,689

73%

Mental Retardation

$ 3,872

53%

Severe Mental Illness

$ 4,454

59%

Dementia

$11,488

Source: Sandra M. Foote and Christopher Hogan, “Disability Profile And Health Care Costs Of Medicare
Beneficiaries Under Age Sixty-Five,” Health Affairs, 20, no.6 (November/December, 2001), pp. 245;
available at http://content.healthaffairs.org/cgi/reprint/20/6/242.pdf.
.

Medicare’s per capita spending on disabled beneficiaries is
somewhat lower than its spending on aged beneficiaries.10
However, disabled beneficiaries with mental disorders are
more costly for the Medicare program than the typical disabled beneficiary: Per capita spending on disabled beneficiaries with mental disorders is over 22 percent higher than
average spending per disabled beneficiary.11 (See Figure 2 for
Medicare spending on disabled beneficiaries across types of
mental disorders.)

figure 3
Distribution of Medicare
Beneficiaries with Mental Disorders,
by Eligibility Class
Any Mental
Disorder

100%

Serious Mental
Illness

80

Mental Disorders Among Aged Beneficiaries
Aged beneficiaries are far less likely to exhibit mental disorders than disabled beneficiaries but, because of the size of
the aged population, most of the Medicare beneficiaries with
mental disorders are over the age of 65. Prevalence of serious
mental illness is more equally divided across aged and disabled Medicare beneficiaries. Nearly half of all beneficiaries
with severe mental illness and about two-thirds of those
with any form of mental disorder are aged. (See Figure 3 for
distribution of Medicare beneficiaries with mental disorders.)
Significant cognitive impairments, such as dementia, clearly
contribute to the prevalence of severe mental illness among
aged beneficiaries, but the extent to which other severe psychiatric conditions influence disease prevalence has not been

44% Aged
Aged 65%

60

40

Disabled 35%

20

56% Disabled

0%
Source: Authors’ calculations based on disease prevalence rates
cited in this paper and population statistics in CMS, “Medicare
Enrollment: National Trends—Medicare Aged and Disabled
Enrollees by Type of Coverage,” 2005; available at www.cms.hhs.
gov/MedicareEnRpts/Downloads/HISMI05.pdf.

Continued on p. 9 
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Disability, Medicare, and Medicaid
Workers who become severely disabled before age 65 and can no longer work are eligible for Social Security
Disability Insurance (SSDI) payments after five months of unemployment. SSDI recipients are subsequently
eligible for Medicare coverage after they qualify and receive SSDI benefits for 24 months. Approximately 34
percent of all such disabled adults with mental disorders are Medicare beneficiaries.
For the Social Security Administration (SSA) “disability” is the inability to work at a job that pays at least
$900 per month (in 2007) because of a medically determinable physical or mental impairment that is expected
to result in death or to continue for at least 12
months. Not all physical and mental conditions
Source of Health Insurance Coverage
are included. For example, drug addiction and
for Persons Disabled by Mental Disorders
alcoholism are not qualifying conditions. Further, people with serious conditions meet the
54% Medicaid
35% Medicare
criteria only after their disease is in an advanced
stage. Maintaining disability status can be par13%
ticularly difficult for mentally ill persons who
Medicaid
12%
can be stabilized and able to work when they
& Medicare
Medicare
are receiving appropriate medical treatment.
10%

Medicare & Private
Dually eligible — Many low-income ben41%
Medicaid
eficiaries who qualify for Medicare due to
a disability also qualify for Medicaid. Most
states provide Medicaid coverage for aged,
blind, and disabled individuals with limited
6%
2%
15%
income who qualify for Supplemental Security
Uninsured
Other
Private
Income (SSI) from SSA. There is no wait time
for SSI eligibility. Approximately 35 percent
Source: Richard G. Frank and Sherry Glied, “Changes In Mental Health
Financing Since 1971: Implications For Policymakers And Patients,”
of SSI recipients qualify as a result of a mental
Health Affairs, 25, no.3 (May/June, 2006), p. 606.
disorder. Approximately 13 percent of all disabled adults with mental disorders are dually
eligible for Medicare and Medicaid. Nearly 40
percent of disabled Medicare beneficiaries with mental disorders are also eligible for Medicaid, compared
to 30 percent of disabled beneficiaries who do not have a mental disorder.

Eligible for Medicaid but NOT Medicare — Some disabled people are ineligible for SSDI and Medicare
because they do not have a sufficient work history but they may be eligible for SSI and Medicaid, depending on their income level and their state’s eligibility criteria. This group also includes disabled children
and people who receive SSDI but have not yet met the two-year waiting requirement for Medicare benefits.
About 40 percent of all disabled adults with mental disorders are eligible for Medicaid but not Medicare.
Eligible for Medicare but NOT Medicaid — Disabled persons with a work history who have fulfilled the two
year wait period will be eligible for Medicare, but some of these individuals will be ineligible for Medicaid
because their income or assets are too high. Approximately 21 percent of all disabled adults with mental
disorders are eligible for Medicare but not Medicaid.
Ineligible for Medicare and Medicaid — Some disabled people will not qualify for Medicaid or Medicare.
This group includes those in the process of fulfilling the two-year waiting period, as well as those who do
not meet the SSA criteria for disability determination. Approximately 22 percent of disabled adults with
mental disorders are ineligible for either Medicare or Medicaid.
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Continued from p. 7

fully documented. Available data suggest that one-quarter to one-half of
severe mental disorders among the aged are due solely to cognitive limitations. Beneficiaries with dementia may have co-occurring psychiatric
disorders, such as depression. The prevalence of other serious mental
disorders, such as schizophrenia, appears to be lower in the aged population, most likely because people with these conditions have high rates of
premature mortality and life-spans that are, on average, 20 years shorter
than the U.S. average.12
Although access concerns often center on the needs of vulnerable individuals with severe mental disorders, mental disorders among aged beneficiaries are more frequently mild to moderate in severity. The three most
common mental disorders experienced by Medicare beneficiaries over the
age of 65, in order of prevalence, are anxiety, dementia or other cognitive
impairments, and depression. The prevalence of dementia doubles every 5
years beyond age 65, becoming the most common mental health diagnosis
after age 80.13 The severity of more common disorders, such as dementia,
can vary considerably, and only a small proportion of those afflicted are
likely to face significant functional impairments.
While the most common types of mental disorders are not usually severe
and disabling, people with these mild to moderate mental health diagnoses
tend to have high rates of other illnesses. The relationship between mental
health disorders and physical disorders such as diabetes, heart disease,
and cancer is not fully understood. In some cases, a single disease process
may be fundamentally responsible for both mental and physical symptoms.
In other cases, underlying mental disorders may undermine adherence
to medical protocols (for example, medication management) and healthy
lifestyle choices, such as diet and exercise, which are known to influence
the onset and management of other chronic diseases. In still other cases,
preexisting physical disorders may lead to decreased functionality and
increased social isolation, which may subsequently trigger mental health
complications. Left untreated, mild to moderate mental disorders can
escalate into more serious mental conditions, complicate the treatment of
physical health conditions, compromise patient outcomes, and increase
the cost of care.

Medicare Policies Related to
Mental Health Services
Medicare covers a wide range of mental health services, but special restrictions and limitations are often applied to differentiate psychiatric benefits
from comparable physical health services. The impact of Medicare’s coverage and payment policies on access to mental health services, quality
of care, and patient outcomes is frequently unclear and sometimes hotly
debated. The following reviews key issues related to Medicare’s coverage
of and payment for mental health services.
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Inpatient Hospital Services
The acute care services needed to diagnose and stabilize individuals in a
mental health crisis have traditionally been provided in inpatient settings.
Follow-up treatment planning and referrals for monitoring or additional
treatment in the community may also begin in an inpatient facility. Care
is delivered through the combined expertise of multidisciplinary teams
that include, among others, nurses, psychiatrists, psychologists, and social
workers. The relative contributions and mix of disciplines appears to vary
considerably across inpatient settings and geographic areas, depending
upon care models, patient mix, and workforce characteristics.
Many mental health experts believe that most
The Medicare statute imposes a 190-day lifeinpatient psychiatric admissions could be
time limit on services received in specialty
avoided if appropriate community-based services were utilized properly. However, such
psychiatric hospitals.
services are often in short supply or difficult
to access. The nature of mental disorders can lead patients to delay, resist,
or refuse necessary treatment until a crisis precipitates intervention. In some
cases, patients can be hospitalized involuntarily if a court determines that
their mental illness has resulted in an immediate danger to themselves or
others. Involuntary hospitalizations typically require admission to a locked,
secure psychiatric unit.
Life-time limit on inpatient psychiatric services — Under Part A, Medicare pays for inpatient psychiatric care provided in both freestanding
psychiatric hospitals and in dedicated psychiatric units of general acute
hospitals. These providers are called inpatient psychiatric facilities (IPFs).
Medicare will also cover inpatient psychiatric services provided in nonspecialized, medical/surgical beds of general hospitals (commonly referred to
as “scatter beds”). Medicare pays for 100 percent of inpatient psychiatric
services, subject to a deductible and copayment for extended stays.
Medicare does not cover long-term custodial care for any condition and
imposes a 90-day limit on all inpatient hospital coverage for each episode
of illness (known as a “benefit period,” which begins on the day the beneficiary enters a hospital or skilled nursing facility and ends when the
beneficiary has been out of the hospital for 60 consecutive days).14 This
limit applies to both psychiatric and general inpatient services. For general
hospital services, there are no coverage limits on the total number of benefit
periods a beneficiary is entitled to in his or her lifetime. However, Medicare
limits lifetime treatment in freestanding IPFs to 190 days.15 Stays in general
hospitals for psychiatric services are not subject to the 190-day limit. The
lifetime psychiatric limit was intended to limit the federal government’s
role in paying for long-term custodial support of the mentally ill. The limit
was not imposed on hospital-based units because these facilities have only
rarely been used for long-term care purposes.
The extent to which the 190-day limit hinders access to inpatient psychiatric services is not clearly understood. Although few beneficiaries reach
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the 190-day lifetime limit, the policy is most likely to affect beneficiaries
disabled by mental illness. These beneficiaries have more frequent psychiatric hospitalizations in a given year and are more likely to be enrolled
in Medicare for a longer period of time than aged beneficiaries. Although
beneficiaries who reach the 190-day limit could still be covered for psychiatric care provided in general hospitals, consumer advocates and providers are concerned that the limit may undermine choice of physician and
jeopardize access to care, particularly in communities where the general
hospitals lack psychiatric capacity.
Prospective payment — Medicare recently revised its reimbursement
policy for IPFs, moving in 2005 from a cost-based system, with limits, to a
per diem prospective payment rate, referred to as the inpatient psychiatric
facility prospective payment system (IPF-PPS).16 The per diem rate varies,
depending on the patient’s psychiatric diagnosis-related group—which
accounts for cost differences across patients that are due to their diagnoses, procedures, and other factors—and on whether the patient has any of
17 coexisting general medical conditions that are associated with higher
average costs. The per diem rate is higher in the early days of a psychiatric
stay, in recognition of the costs associated with stabilizing a psychiatric
patient.17 Care provided in scatter beds is reimbursed under the per case
hospital inpatient prospective payment system (PPS).
The impact of the IPF-PPS on access to care is uncertain at this time, since it
is still in its three-year phase-in period. Psychiatric providers are cautiously
monitoring its effect on a market that has experienced significant fluctuation
in inpatient psychiatric capacity over the past two decades. Some worry that
the IPF-PPS may encourage general hospitals (which tend to have higher average cost structures than freestanding facilities) to further reduce inpatient
psychiatric capacity in favor of more reliably profitable medical services or
to shift beds from specialized units to scatter beds, which will not be reimbursed under IPF-PPS. In 1995, nearly one-third of all Medicare inpatient
psychiatric discharges were from scatter beds; this proportion has increased
as dedicated psychiatric capacity in both freestanding facilities and general
hospitals has decreased over the last decade. Some experts have expressed
concerns that the care delivered through scatter beds is not as effective as
the care delivered in more specialized facilities. Adding to their concern is
the inability of most scatter beds to accommodate involuntary admissions
because they lack the security measures required to contain patients who
have been hospitalized against their will.
Others believe that the payment system may be advantageous to freestanding hospitals that have lower cost structures and more flexibility to target
services to patient needs. Some believe that, while less efficient providers
might eliminate psychiatric services, organizations that have developed
the expertise and economies of scale to deliver psychiatric services in the
most efficient manner could expand their operations, resulting in little
overall change in capacity levels.
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Partial Hospitalization
Partial hospitalization programs, used in lieu of inpatient hospitalizations,
provide structured, intensive outpatient services. These programs, sometimes referred to as day programs, offer a range of medically appropriate
services “wrapped around the particular needs of the patient.”18 The services
generally reflect a multidisciplinary team approach to patient care under
the direction of a physician and are typically much more intensive than
those offered through the private practice of an individual mental health
provider, such as a psychiatrist or psychologist.19 Partial hospitalization
programs do not provide around-the-clock nursing care, but supervised
residential facilities may be offered through affiliated organizations.
Some advocates question the effectiveness of partial hospitalization programs. The lack of around-the-clock supervision may make these programs
inappropriate for patients who have not been stabilized. At the same time,
the institutional nature of these programs hinders the development of
behavioral skills and coping strategies in a real-world, community-based
context. Furthermore, partial hospitalization programs often do not include
the kinds of psychosocial services (such as vocational training and housing assistance) that are known to support recovery from mental disorders
because such programs tend to focus solely on clinical services that are
reimbursable through Medicare and commercial insurers.
Regulatory concerns — Partial hospital services were added as an explicit
Medicare-covered benefit through the Omnibus Budget Reconciliation Act
of 1987. Previously, mental health services delivered through hospitalbased partial hospitalization programs were sometimes covered as a Part
A (inpatient) benefit, and freestanding partial hospitalization programs
were sometimes covered as a Part B (outpatient) benefit, depending on
the policies of Medicare contractors charged with administering claims.
Partial hospitalization coverage and reimbursement policies have been the
source of considerable controversy over the past decade. Providers complained that the Centers for Medicare & Medicaid Services (CMS) was slow
to issue a national review standard when the benefit was first established,
allowing Medicare contractors to implement variable review procedures
that limited access in some areas and inadequately regulated services in
others. After payments to freestanding partial hospitalization programs
rose sharply between 1993 and 1997, increasing nearly 500 percent (from
$60 million to $349 million), a series of investigative reports revealed that
several providers billing for this care delivered care that failed to include
the mandated set of partial hospitalization services and was not sufficiently
intensive and therapeutic in nature. 20 Much of this substandard care was
delivered to patients who did not meet the medical necessity criteria for
partial hospitalization services. Once apprised of fraud and abuse problems, CMS intensified scrutiny and decertified many providers across
the nation. Also, prospective payment for partial hospitalization services,
implemented in 2000, established a fixed payment amount for the bundle
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of services offered through the program21 and minimized opportunities
and incentives for fraud.

Outpatient Services
Outpatient mental health can include a diverse mix of clinical services,
including diagnostic testing, psychotherapy, targeted case management,
medication management, and psychosocial services. These services are
provided by primary care physicians,
Under Medicare, outpatient psychotherapy
nurse practitioners, and physician assistants, as well as by specialty mental health
services are subject to a 50 percent coinsurance.
providers, such as psychiatrists, clinical
psychologists, psychiatric nurse specialists, and social workers. The specific scope of practice for these professional disciplines is dictated by state
licensure laws and can vary substantially from state to state.
Medicare Part B pays for professional services delivered in hospital and
outpatient settings and, since 1989, has allowed billing from a broad range
of nonphysician mental health service providers subject to state licensing
parameters.22 However, most mental health services covered by Medicare
are provided by primary care physicians. More than half (51.6 percent) of
patients treated for major depression are seen in the general medical sector and are cared for exclusively by primary care or other nonpsychiatrist
physicians.23 It is also estimated that 67 percent of psychopharmacological
drugs are prescribed by primary care physicians.24
Coverage limitations — Medicare has an outpatient mental health limitation that imposes a 50 percent coinsurance on psychotherapy services
(including individual, family, and group psychotherapy).25 Other mental
health services (such as inpatient therapy services, diagnostic testing,
psychological evaluation, and brief visits to monitor the efficacy of prescribed medications) are subject to the standard 20 percent coinsurance.26
Psychosocial services are generally not covered by Medicare.
The higher coinsurance level for the most common forms of outpatient
mental health treatment was originally established to deter inappropriate
utilization. Policymakers believed that these services were particularly
vulnerable to overutilization for a variety of reasons, including the noninvasive nature of such services, the lack of objective biomarkers to validate
diagnoses of mental disorders, and biases regarding the legitimacy of mental
disorders and mental health treatment.27 Differential cost sharing for mental
health services was once common practice in commercial insurance products, but many private health insurance plans have moved away from this
approach as a result of the adoption of more effective, targeted utilization
management techniques; the enactment of state laws requiring parity for
mental health coverage; and a growing recognition that untreated mental
illness can fuel overall health care spending.
The Office of the Inspector General (OIG) within the Department of Health
and Human Services (DHHS) recently found that Medicare carriers have
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adopted inconsistent policies regarding the application of the limitation,
which has led to wide geographic variation in beneficiary copayment
obligations.28 Among the 57 carriers studied, nine different policies for the
application of the limitation were identified. In over one-half of the service
areas, carriers subjected evaluation and management services to patients
with Alzheimer’s disease to the limiMedPAC has recommended that the outpatient
tation, contrary to federal regulations.
Although CMS has issued guidance
mental health limitation be eliminated.
related to the limitation, the OIG found
that this guidance was not sufficiently detailed to ensure uniform implementation across carriers and recommended that new guidance be issued.
Patient advocates have expressed concern that more onerous cost-sharing
obligations for outpatient mental health benefits under Medicare discourage
beneficiaries from seeking necessary services and may significantly limit
access to treatment for beneficiaries who lack the financial resources or
supplemental insurance to fulfill the 50 percent coinsurance requirement.29
The restriction applies only to psychotherapy services but, especially given
inconsistent policies among carriers, concerns have been raised that both
patients and providers may believe the higher copayment requirement
applies to all outpatient mental health services, discouraging use of diagnostic and other services not subject to the higher copayment.
Access barriers are perhaps most significant for those dually eligible for
Medicare and Medicaid.30 While Medicaid is responsible for covering
the Medicare coinsurance of dual eligibles, state Medicaid programs can
elect to withhold such payment if the amount paid by Medicare meets or
exceeds the Medicaid payment rate for that service. Because Medicaid reimbursement rates for professional services are generally very low relative
to Medicare, mental health service providers may be unable to recoup the
coinsurance payment from either Medicaid or low-income dually eligible
beneficiaries. Although this dynamic also holds true for outpatient treatment of physical health conditions, the 50 percent effective “discount” on
mental health providers’ service fees is far more substantial than the 20
percent “discount” imposed on physical health services.
The Medicare Payment Advisory Committee (MedPAC) has recommended that the outpatient mental health limitation be eliminated,31 finding
that the modest increase in program costs likely to result from this action
($500 million in 2002) is justified in light of the access improvements
and cost-sharing simplifications that would be achieved. Skeptics question whether a more generous outpatient mental health benefit would
significantly improve appropriate access and worry that inappropriate
utilization could increase.
Ambiguous billing requirements — The willingness of mental health
providers to serve Medicare beneficiaries may be further compromised
by confusion regarding reimbursement policies and practices that result
in protracted adjudication processes and a high rate of claims denials. Up
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to 20 percent of claims for medication management services and up to 50
percent of claims for group therapy services are denied. Denials are made
for a variety of reasons, and some proportion of these denials are likely
valid. The DHHS OIG concluded that one-third of outpatient mental health
services provided to Medicare beneficiaries were medically unnecessary,
billed incorrectly, rendered by unqualified providers, or improperly documented. Group therapy services and psychological testing were found to
be particularly problematic.32
Many providers believe that local policies
Up to 20 percent of claims for medication
set by Medicare carriers for outpatient
management services and up to 50 percent of
mental health services are too vague, too
narrowly defined, or too often misapplied,
claims for group therapy services are denied.
resulting in inappropriate denial of claims
or costly resubmissions in order to supply necessary documentation. Providers complain that mental health services are subject to variable and poorly
articulated payment rules. Medicare limits coverage to services that are
medically “reasonable and necessary for the diagnosis or treatment of illness
or injury or to improve the functioning of a malformed body member.”33
Relatively few criteria for making specific coverage decisions are set at the
national level. Rather, Medicare carriers are given a fair degree of latitude
in establishing rules to assess medical necessity and set service-specific
requirement to ensure the appropriateness of services. Inconsistency in
coverage policies across regions is not unique to mental health services,
but mental health providers believe that the diversity of practices related
to specialty mental health services adds to the confusion.
Providers also believe that carriers implement established policies improperly. For example, some carriers have policies stating that psychotherapy
services for patients with cognitive impairments will not be covered if the
severity of those cognitive limitations precludes the patient from deriving
meaningful benefit from the therapy. Approximately 30 percent to 40 percent of people with dementia also have co-occurring mental disorders such
as depression or psychosis34 that may be helped through psychotherapy,
but these comorbid disorders often go undiagnosed or undertreated.35
Providers report that Medicare carriers routinely deny claims for mental
health services delivered to any individual with dementia, regardless of
severity level, despite evidence that patients with mild to moderate dementia benefit from psychological interventions that improve functioning
and coping. Documentation requirements to validate severity level are not
clearly delineated.
Screening services — Mental health screenings to identify conditions that
may not be readily apparent to providers are not covered for most existing Medicare beneficiaries, but a new “Welcome to Medicare,” one-time
physical examination that includes depression screening is covered for
any new beneficiary joining the program after January 1, 2005. In general,
Medicare does not cover preventive health screenings, except for certain,
statutorily defined services. This initial preventive physical examination
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was added as a benefit by the Medicare Prescription Drug, Improvement
and Modernization Act of 2003 (MMA) and includes a broad range of
preventive services. Although depression screening is explicitly identified
as a component of the physical, Medicare does not require or recommend
any specific screening tool.
Primary care physicians believe that many of the standardized, validated
depression screening tools are too cumbersome to administer during
a short office visit. The American Academy of Family Physicians has
advised an approach recommended by the U.S. Preventive Services
Task Force.36 This approach, the PHQ-2, involves asking two questions:
“Over the past two weeks, have you felt down, depressed or hopeless?”
and “Over the past two weeks, have you felt little interest or pleasure in
doing things?” Answers can either be yes/no or scaled from zero (not at
all) to three (nearly every day). An affirmative answer to either question
should prompt seven additional questions that provide more detailed
evaluation for depression. The extent to which the “Welcome” physical in general and the depression screen in particular will be used is as
yet unclear. Patient advocates have raised concerns that even if these
screenings are helpful for new beneficiaries, coverage is not available for
either screening beneficiaries enrolled before January 2005 or conducting
periodic reassessments.
psychiatric practice incentives — Psychiatrists have increasingly discontinued offering psychotherapy as a component of their practice, preferring to focus on more lucrative medication management services. The
financial incentives established by Medicare and other payers encourage
psychiatrists to provide psychopharmacologic treatments in contrast to
psychotherapy. Reimbursement rates show a clear economic advantage
to providing medication with brief follow-up visits and a clear financial
disincentive to provide psychotherapy37. Psychiatrists earn about $100 less
an hour for providing one 45- to 50-minute session of psychotherapy than
for providing three medication management visits in the same time. Some
private managed care organizations expressly prohibit psychiatrists from
providing psychotherapy. Inadequate psychotherapy training in some
psychiatric residency programs appears to reinforce the trend away from
psychotherapeutic approaches. These forces have made the delegation
of psychotherapy services—if they are offered at all—to nonphysician
providers common practice, with little coordination between therapists
and prescribing physicians.
Many worry that this practice of “splitting” treatment has a negative
impact on the quality of patient care and patient outcomes. Opinions differ as to the best way to resolve this problem. Some would advocate for
psychiatrists to increase their involvement in providing psychotherapy.
Others believe that the delegation of psychotherapy to less highly compensated, yet qualified, professionals is economically efficient and desirable but worry that these providers are not properly trained to monitor
prescription drug use. Still others advocate giving limited prescription
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privileges to psychologists. Some would argue that more should be done
to build a team approach to service delivery.
Reimbursement of nonphysician providers — The central role of nonphysician providers in delivering psychotherapy suggests that these are
the providers most likely to be influenced by Medicare’s outpatient mental
health limitation. For many of them, the financial disincentives of the higher
copayment level are compounded by other reimbursement policies that
decrease their payment levels relative to those of physicians. Nonphysician
providers recognized by Medicare receive different rates for their services.
For example, psychologists are paid 100 percent of the physician fee schedule, whereas social workers receive 75 percent of the physician rate. In
addition to psychologists and social
workers, Medicare also makes direct Although pharmacological interventions are most
payment to nurse practitioners with effective when delivered in combination with psythe equivalent of a master’s degree
in psychotherapy and to clinical chotherapy, nearly half of all patients taking psypsychiatric nurse specialists. Other chotropic drugs receive no other form of treatment.
types of mental health service providers, such as licensed professional clinical counselors and marriage and
family therapists, can only be paid indirectly by Medicare (for example,
through a physician who employs, supervises, and pays them) and only in
limited circumstances.
It has been argued that expanding the number of professional disciplines
approved for direct payment from Medicare and raising the payment
rates for professions paid below the physician fee schedule could improve
access to mental health services, particularly in rural areas with health
provider shortages. However, MedPAC recently recommended against
such expansions, finding that, although utilization would probably rise,
the increase in program costs likely to result from this action would not
represent a prudent use of resources.

Prescription Drugs
Psychotropic drugs, broadly defined, include any chemical substance that
alters brain function. Psychotropic medications commonly used to treat
mental disorders include antidepressants, antipsychotics, antianxiety
agents, and stimulants. Increasingly a central component in the treatment
of mental illness, such drugs were used in 75 percent of mental health
treatment cases in 2001.38 Pharmacological interventions are most effective
when delivered in combination with psychotherapy.39 However, for nearly
half of all patients taking psychotropic drugs, medication is the only form
of treatment received.40
Psychotropic medications can be particularly complicated to monitor, and
establishing effective treatment regimens for vulnerable patients with cooccurring neurological disorders is complex. Individuals with severe mental impairments may resist changing medications because treatment often
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requires considerable trial and
error before an effective medication or medication combination
can be identified. Disruptions in
medications can be dangerous
for these individuals, resulting
in rapid deterioration, impaired
functioning, increased health care
utilization, and overuse of more
expensive urgent care services
and inpatient hospitalizations.

figure 4
Average Annual Drug Spending Among Medicare Beneficiaries
DISABLED
Not in Medicaid

Drug
g Spending
p

AGED

Not in Medicaid

Dually Enrolled

Dually Enrolled

Mental Disorder
3,000
2,500

Mental Disorder

2,000

Medicare Part D began covering outpatient prescription psy1,500
chotropic and other drugs in
1,000
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stand-alone prescription drug
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0
Medicare Advantage managed
No Mental Disorder
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care plans (both types referred
to here as “drug plans.”) In
Psychotropic Drugs
general, individual plans have
Non-Psychotropic Drugs
a great deal of latitude in determining which drugs are
Source: Adapted from exhibit 5 in Julie Donohue, “Mental Health In The Medicare Part D Drug Benefit:
included on a plan’s formulary
A New Regulatory Model?” Health Affairs, 25, no. 3 (May/June 2006), p. 711.
and cost-sharing requirements,
but the formulary and benefit design must be approved by CMS. Beneficiaries can select from the drug plans available in their geographic region.
Dually eligible enrollees were automatically enrolled in drug plans in
an attempt to avoid gaps in coverage as these beneficiaries transitioned
from Medicaid to Part D coverage.
Protections — CMS recognized that private health plans would have some
incentive to discourage enrollment by high-risk, costly populations, including those with mental illness, and implemented protections to minimize risk
selection. Beneficiaries with a mental disorder have high per capita drug
expenditures,41 spending, on average, 61 percent more on drugs than beneficiaries without mental illness.42 (See Figure 4 for average drug spending
among Medicare beneficiaries.) In order to minimize the development of
benefit designs and enrollment strategies biased against such high-cost
patients, CMS required drug plans to conform to a variety of safeguards.
n Protected drug classes. Plans are required to cover “all or substantially

all” drugs available in six special classes: antidepressants, antipsychotics, anticonvulsants, antineoplastics, antiretrovirals, and immune
suppressants.43 These drug classes are essential to vulnerable groups
known to have high prescription drug costs, such as people with mental
illness, HIV/AIDS, and cancer.
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n Utilization management. Drug plans are precluded from imposing

utilization management (such as prior authorization, quantity limits,
and step therapy) on individuals who were stabilized on drugs in
protected drug classes before being enrolled in the drug plan.44 Plans
must also continue coverage for protected medications during the
annual benefit period, even if the medication is removed from the
formulary. However, plans can apply utilization management tools on
any prescription initiated after enrollment in the plan (such as new or
different medications or dosage changes). It is not clear how long these
protections will remain in place, and plans are not required to provide
all doses and forms of a medication (for example, continuous release
formulations), which can be particularly problematic for psychotropics
because many are prescribed “off-label” at dosage levels that have not
been evaluated by the Food and Drug Administration.45

n Cost sharing. Plans have flexibility in determining placement of drugs

on cost-sharing tiers within the formulary. However, plans are explicitly
prohibited from using their formularies to discriminate against any
class of beneficiaries, and CMS has reviewed drug plans’ cost-sharing
requirements to ensure that protected drug classes are not systematically assigned to the highest cost-sharing tiers.

“Benzos” exclusion — Although Part D mandates coverage for many
of the psychotropic drugs used to treat mental illness, some types of
psychotropic drugs (such as antidementia medications) are not in a
protected class, and benzodiazepines are statutorily excluded from
coverage. Benzodiazepines,
which are tranquilizing agents,
table 1
have been the subject of controPercentage of Medicare Beneficiaries Using Psychotropic Drugs
versy for several decades. These
by Therapeutic Category and Eligibility, 2002
medications can lead to dependency, and drug-related adverse
Disabled
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Disabled
aged
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Dually
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Eligible
Other
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Other
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taking this drug. Nonetheless,
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Use by
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0.1
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3.4
2.2
overview of psychotropic drug
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6.6
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0.5
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eligibility class.) Abrupt termi*Percentages of use in therapeutic categories will exceed drug use total because some beneficiaries use
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lead to severe withdrawal reacSource: Adapted from exhibit 2 in Julie Donohue, “Mental Health In The Medicare Part D Drug Benefit:
tions.46 In large part because of
A New Regulatory Model?” Health Affairs, 25, no. 3 (May/June 2006), p. 710.
these clinical concerns, all state
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Medicaid programs have historically provided some level of coverage
for benzodiazepines, despite the fact that the Medicaid statute allows
states to exclude coverage of these drugs at their discretion.
Transitions from Medicaid to Medicare — Advocates have raised concerns about how coverage changes could affect the more than 6 million
beneficiaries who are dually eligible for Medicaid and Medicare, 39 percent
of whom have mental disorders. Access to psychotropic drugs is likely to
improve for many Medicare beneficiaries who did not have prescription
drug coverage before the implementation of Part D but, for dually eligible
people, the transition could be problematic. Enrollment in Part D was
mandatory for the dual eligibles who had received drug coverage through
state Medicaid programs before 2006. Duals in some states may encounter
new formulary rules and higher cost-sharing requirements. Some Medicaid
programs exempt psychotropics from utilization management restrictions,
and pharmacists are legally required to fill prescriptions, regardless of the
individual’s ability to pay the copayment amount. Sources of drug spending for Medicare beneficiaries are shown in Figure 5.
Under Medicare Part D, dual eligibles will continue to be exempt from
paying premiums or deductibles (as they were under Medicaid) if they are
enrolled in below-average premium plans. However, they are responsible
for low copayments ($1 for generic drugs and $3 for brand name drugs,
depending upon their income) and pharmacists are now able to require copayments before filling prescriptions. Studies have shown
that even small copays can significantly lower utilization
figure 5
of prescription drugs among low-income populations.47
Sources of Prescription Drug Spending
These copayments, though seemingly small, can be a sigfor Medicare Beneficiaries, 2002
nificant burden for duals with multiple chronic conditions
who struggle to cover costs of several medications with
Psychotropic
All Other
SSDI or Social Security subsidies that are often inadequate
Drugs
Drugs
48
to cover housing and food costs.
15.0%
27.4%
Risk adjustment — Federal payments to drug plans are
intended to minimize the disincentives associated with
enrolling high-cost patients, such as those with mental
disorders, by (i) tying payment level to the risk associated
with individual enrollees and (ii) limiting the collective
risk incurred by plans through the use of risk corridors
and reinsurance payments for larger-than-expected catastrophic expenses. A new risk adjustment model designed
for Part D adjusts payments based on age and specific
comorbidities. The risk adjuster accounts for 23 percent
of the variation in drug spending. Although the Part D
risk adjuster appears to offer an improvement over older
risk adjustment models and is considered to offer fairly
generous protection, the extent to which it obviates risk
selection incentives is not yet clear. Patient advocates worry
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that plans may still have financial incentives to use aggressive utilization management tools and pricing practices to discourage enrollment
by persons with mental illness.49

Care Management
Efforts to improve the management and integration of the multiple mental
health services covered under Medicare are limited. Medicare’s struggle to
coordinate care and control costs under a largely fee-for-service program
lacking robust utilization management mechanisms has led Congress to
explore the utility of private market disease management programs, which
focus on coaching patients, rather than attempting to influence provider
practices directly. The recent Medicare Health Support program authorized by the MMA pays participating disease management vendors and
insurance plans a monthly per beneficiary fee for managing a population
of chronically ill beneficiaries.
To date, no disease management effort has focused on a mental disorder,
and few have incorporated mental health screening and care coordination to
address the impact of mental comorbidities on physical conditions like diabetes. Given the prevalence of mental disorders in the Medicare population
and the association of mental disorders with higher health care spending, a
strengthened emphasis on mental health could prove useful.
Medicare managed care plans do not appear to have made great strides
beyond the fee-for-service program. Mental health benefits, care management techniques, and outcomes have not been rigorously studied in
Medicare managed care plans. Available evidence suggests that Medicare
+Choice (now Medicare Advantage) plans provide poorer quality mental
health services than employer-sponsored managed care plans.50 In only
one area—mental health—do Medicare managed care plans score lower
than their employer-sponsored counterparts on quality of care measures.
Fewer Medicare beneficiaries receive appropriate follow-up after hospitalization for a mental illness and fewer receive appropriate management
of their antidepressant medications. These findings suggest that Medicare
managed care plans have not taken steps to optimize use of appropriate
mental health services and have likely modeled their benefits on the existing fee-for-service structure. This is not surprising, as more generous
benefits relative to the traditional program could lead to adverse risk selection for the plans, which have no incentive to attract high-need patients
with mental disorders.
Managing care for beneficiaries with severe mental illnesses is especially
challenging because these patients need psychosocial, rehabilitative, and
supportive services that are not typically covered through traditional insurance programs outside of Medicaid. Such services recognize that the nature
of mental illness interferes with treatment compliance and assists people
at various stages of the recovery process to reduce distress and prevent
relapse or rehospitalization. Studies have shown psychosocial models to be

National Health Policy Forum | www.nhpf.org

21

Background Paper
November 27, 2006

more effective at identifying and delivering mental treatment, improving
activities of daily living, and reducing utilization of inpatient and other,
nonpsychiatric health care services.51 The addition of these services, while
cost-effective in terms of the outcome improvements achieved, may not be
cost-saving. Therefore, it will be difficult for managed care organizations
to implement evidence-based practices if the costs of psychosocial support
services are not factored into their capitation rates.
While dual eligibles have some access to rehabilitative and psychosocial
services through Medicaid and local state agencies, care management for
these beneficiaries is complicated by the complexity of coordinating coverage and payment policies across Medicare and Medicaid. A recent MedPAC
report identified a number of conflicts, inconsistencies, or unclear policies
that have the potential to hinder care delivery for dual eligibles.52 MedPAC
recommended that many of these coverage and payment issues could be
alleviated if dual eligibles were enrolled in the same plan for both Medicareand Medicaid-covered services and the plan took steps to integrate benefits.
This integration has occurred in
demonstration projects, such as
A recent MedPAC report identified a number of conthe Program of All-Inclusive
flicts, inconsistencies, or unclear policies that have
Care for the Elderly (PACE)
and the Wisconsin Partnership
the potential to hinder care delivery for dual eligibles.
Program. However, the costeffectiveness of these plans has not been well established and they serve
only a small fraction of dual eligibles.
Medicare Advantage Special Needs Plans (SNPs), authorized by the MMA,
offer another potential avenue to better manage care for Medicare beneficiaries with mental disorders, but a SNP focused on this population has
not yet been developed. SNPs provide an opportunity to integrate acute
and long-term care services and increase coordination of Medicare and
Medicaid financing and benefit structures. These plans are subject to the
same rules and requirements as other Medicare Advantage plans but they
are able to provide products focused exclusively on specialized populations, such as the dual eligibles, the institutionalized, and other chronically
ill populations. SNPs may limit enrollment to one of the special needs
populations, tailoring benefits and provider networks to best meet the
needs of these vulnerable groups. Concerns have been raised that SNPs
are not required to coordinate with state Medicaid programs and may do
little to integrate care for vulnerable populations.

Medicare Spending
for Mental Health Services
Medicare expenditures for mental health services reflect the program’s
benefit design. Before the introduction of Part D, Medicare spending on
mental health accounted for a relatively small proportion of total mental
health expenditures and an even smaller proportion of total Medicare
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spending. Medicare spending on all mental health
services in 2001 was $7.2 billion, representing 3
percent of all Medicare spending ($242 billion).
In contrast, mental health as a proportion of all
health care expenditures accounted for 12 percent
of Medicaid funds and 4 percent of spending by
private insurance in 2001.53 Mental health spending across payers is presented in Figure 6.
The limited nature of Medicare’s mental health
benefits has shielded the program from the
mental health costs of its beneficiaries. Although roughly 20 percent of all persons with
mental disorders are covered by Medicare,54
the program contributes only 7 percent of total
spending on mental health services. This disproportionately low funding rate is attributed
to the absence of a prescription drug benefit
prior to 2006, limited coverage for outpatient
services, and other benefit design features that
may decrease covered spending and limit service utilization for mental health services.

figure 6
Mental Health Spending by Payer Class, 2001
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Source: Tami L. Mark et al.,”U.S. Spending For Mental Health And Substance
Abuse Treatment, 1991–2001,” Health Affairs Web Exclusive (March 29 2005),
p. W5-137.

Total mental health spending by Medicare beneficiaries55 has historically been heavily skewed
toward inpatient services, with 56 percent of
the total going to inpatient care and only 30 percent toward outpatient
services. This relationship is in contrast to national trends showing a reversal in inpatient and outpatient spending over the past decade, during
which inpatient spending declined from 40 percent to 24 percent while
outpatient spending increased from 36 percent to 50 percent of all mental
health spending.56

Medicare’s mental health costs, while small relative to those of other payers, have been rising rapidly in recent years. The growth rate for Medicare
spending on mental health services increased from 3 percent to 7 percent
over the past decade, making it second only to Medicaid’s. This growth is
attributed to the rising number of Medicare beneficiaries who qualify for
the program as the result of a mental health disability.57
With the advent of Part D, the growth of mental health spending under
Medicare will accelerate significantly. Medicaid spending on psychotropic
medications for dually eligible beneficiaries totaled more than $6.3 billion
in 2002—an amount almost equal to total mental health expenditures by
Medicare in 2001. This suggests that Medicare spending for mental health
services will at least double as a result of Part D. Spending increases will
likely be even higher in light of psychotropic drug expenditures associated with non–dual eligibles and apparent increases in psychotropic drug
prices relative to those paid by state Medicaid programs. Because these
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drugs were in a protected class, drug plans contend that they had little
leverage to negotiate price on these products with manufacturers. Plans
were mandated to cover a broad range of products in protected classes
and, therefore, had little latitude to offer volume guarantees in exchange
for price discounts.
Although prescription drug costs have not been a significant cost factor for
Medicare until recently, it is important to note that psychotropic medications
account for almost all growth in mental health spending for other public
and private insurance plans over the last 15 years. In 1987, 7.7 percent of
all mental health care spending in the United States was for psychotropic
medications. By 2001, spending on psychotropic drugs accounted for 21
percent of total mental health spending.58 Between 1992 and 1997, total
U.S. spending on psychotropic drugs grew at twice the rate of total drug
spending and, since 1997, spending growth for psychotropic medications
has outpaced both total health care spending and total drug spending.59
In 2003, more than $18 billion was spent on antidepressant and antipsychotic drugs.60 Figure 7 displays growth in psychotropic drug spending
as percentage of total mental health spending.

Conclusion
A dramatic increase in spending for mental health services under Medicare,
resulting largely from the introduction of the prescription drug benefit,
has the potential to trigger a much broader assessment of the program’s
mental health policies. As Medicare expenditures for mental health begin
to more accurately reflect the burden of disease borne by beneficiaries,
policymakers may take a much closer look at the value of the services being
purchased. The conclusions they reach could well hinge on an assessment
of the effectiveness and efficiency of the services delivered, along with an
exploration of the extent to which financing incentives are contributing
to these clinical practices: Are the “right” mental health services being
delivered to the “right” Medicare beneficiaries at the “right” time at the
“right” price?

figure 7
Psychotropic Drug
Expenses as a Percentage
of Overall Mental Health
Spending, 1987–2001
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Source: Richard G. Frank, Rena M. Conti,
and Howard H. Goldman, “Mental Health
Policy and Psychotropic Drugs,” Milbank Quarterly, 83, no. 2 (2005), pp.
271–296; available at www.macfound.
org/atf/cf/%7bb0386ce3-8b29-4162-8098e466fb856794%7d/mental%20health%
20ftf%203%2006.pdf.

While the same questions could be posed for any service covered by
Medicare, mental health services have often been singled out for special
consideration, and the influence of these “exceptional” policies is unclear.
Medicare and other insurers have often treated mental health services
differently from other services because mental health care can differ significantly from the traditional medical model. Medicare’s mental health
policies are often debated in a piecemeal, disjointed fashion, frequently
as footnotes to more global policy changes. There may be some benefit to
considering Medicare’s mental health policies more holistically in order
to better consider how these policies interact and reinforce (or contradict)
each other.
In monitoring protections developed under Part D to prevent discrimination
against persons with mental illness and other costly conditions, policymakers
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may find it necessary to consider how policies related to other services are
influencing psychotropic drug utilization. Assessing the impact of restrictions on outpatient mental health services, tracking the influence of prospective payment on inpatient psychiatric capacity, exploring mechanisms to
better leverage Special Needs Plans and other care management strategies,
and examining eligibility policies for disabled persons are among the issues
that may come under further scrutiny as Medicare’s spending on those with
mental disorders continues to rise.
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